Lisata Therapeutics Inc (LSTA)

[F1ash]

The potential of stem cells.

Ottawa team proves stem cell/chemo combo halts MS

"The clinical trial involved 24 patients and tracked their progression over several years. According to The Ottawa Hospital’s news release, after the treatment:

Not a single participant experienced a clinical relapse (zero relapses in 179 patient-years), whereas before treatment, the participants experienced an average of 1.2 relapses per year.

Not a single new active inflammatory lesion could be detected in the brains of any of the participants.

Not a single participant required MS-specific drugs to control their disease.

70% of participants experienced a complete stop in disease progression.

The average rate of brain shrinkage, typically a measure that correlates with MS progression, returned to levels associated with normal aging.
40% of participants experienced some lasting reversal of such symptoms as vision loss, muscle weakness and balance problems.

Some participants were able to return to work or school, regain the ability to drive, get married and have children.

http://stemcellfoundation.ca/en/2016/06/09/ottawa-team-proves-stem-cellchemo-combo-halts-ms/